The in-vitro activity of LY333328, a new glycopeptide, against clinical isolates of vancomycin-resistant enterococci

Advances in Experimental Medicine and Biology

Volumn 418, Issue , 1997, Pages 483-485

  Kirk, Monica ^a   Hill, Robert L R ^a   Casewell, Mark W ^a   Beighton, David ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; GLYCOPEPTIDE; ORITAVANCIN; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERICIDAL ACTIVITY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONFERENCE PAPER; DRUG ACTIVITY; ENTEROCOCCUS FAECALIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0030851678     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1825-3_115     Document Type: Conference Paper

References (8)

1. Handwerger. S., B. Raucher, D. Altarac, J. Monka, S. Marchione, K. Y. Singh, B. E. Murray. J. Wolff, and B. Walters. 1993. Clin. Infect. Dis. 16:750-755.
2. Hill, R.L.R., Smith, CT., Sayed-Akhavani, M. Casewell. M.W. 1996. J Antimicrob Chemother. in press.
3. Lin, Y., R. E. Stratford, L. L. Zornes, W. L. Confer, V. Vasudevan, T. W. Jones. T. I. Nicas. D. A. Preston, C. J. Boylan, D. L. Zeckner, B. J. Boyll. 1995. ICAAC September 17-20 Abs F254.
4. National Committee for Clinical Laboratory Standards. 1993. National Committee for Clinical Laboratory Standards, Villanova, Pa.
5. Pearson, R. D., R. T. Steigbigel, H. T. Davis, S.W. Chapman. 1980. Antimicrob. Agents Chemother. 18:699-708.
6. Spera, R. V., B. F. Farber. 1994. Drugs 48:678-688.
7. Yao, R. C., L. W. Crandall. 1994. In R. Nagarajan (ed.), Glycopeptide antibiotics. Marcel Dekker, Inc., NY.
8. Wade, J.J. 1995. J Hosp Infect 30, Suppl. 1, 483-493.